Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes.
10.4062/biomolther.2017.095
- Author:
Jeong Tae KIM
1
;
Sonia BARUA
;
Hyeongmin KIM
;
Seong Chul HONG
;
Seung Yup YOO
;
Hyojin JEON
;
Yeongjin CHO
;
Sangwon GIL
;
Kyungsoo OH
;
Jaehwi LEE
Author Information
1. College of Pharmacy, Graduate School of Pharmaceutical Management, Chung-Ang University, Seoul 06974, Republic of Korea. jaehwi@cau.ac.kr
- Publication Type:Original Article
- Keywords:
Genistein;
Solid lipid particles;
Particle size;
Oral bioavailability;
Dissolution behavior;
Glyceryl palmitostearate
- MeSH:
Absorption*;
Animals;
Biological Availability*;
Drug Liberation;
Genistein*;
Nanoparticles*;
Particle Size*;
Powders;
Rats
- From:Biomolecules & Therapeutics
2017;25(4):452-459
- CountryRepublic of Korea
- Language:English
-
Abstract:
In this study, the effect of particle size of genistein-loaded solid lipid particulate systems on drug dissolution behavior and oral bioavailability was investigated. Genistein-loaded solid lipid microparticles and nanoparticles were prepared with glyceryl palmitostearate. Except for the particle size, other properties of genistein-loaded solid lipid microparticles and nanoparticles such as particle composition and drug loading efficiency and amount were similarly controlled to mainly evaluate the effect of different particle sizes of the solid lipid particulate systems on drug dissolution behavior and oral bioavailability. The results showed that genistein-loaded solid lipid microparticles and nanoparticles exhibited a considerably increased drug dissolution rate compared to that of genistein bulk powder and suspension. The microparticles gradually released genistein as a function of time while the nanoparticles exhibited a biphasic drug release pattern, showing an initial burst drug release, followed by a sustained release. The oral bioavailability of genistein loaded in solid lipid microparticles and nanoparticles in rats was also significantly enhanced compared to that in bulk powders and the suspension. However, the bioavailability from the microparticles increased more than that from the nanoparticles mainly because the rapid drug dissolution rate and rapid absorption of genistein because of the large surface area of the genistein-solid lipid nanoparticles cleared the drug to a greater extent than the genistein-solid lipid microparticles did. Therefore, the findings of this study suggest that controlling the particle size of solid-lipid particulate systems at a micro-scale would be a promising strategy to increase the oral bioavailability of genistein.
